The dangers of compounded bioidentical hormone replacement therapy-Reference-Cited by-同舟云学术

The dangers of compounded bioidentical hormone replacement therapy

Published:2019-10-31 Issue:688 Volume:69 Page:540-541
ISSN:0960-1643
Container-title:British Journal of General Practice
language:en
Short-container-title:Br J Gen Pract

Author:

Newson Louise,Rymer Janice

Publisher

Royal College of General Practitioners

Subject

Family Practice

Reference17 articles.

1. Menopause and diabetes: EMAS clinical guide;Slopien;Maturitas,2018

2. The National Institute for Health and Care Excellence (2015) Menopause: diagnosis and management NG23, https://www.nice.org.uk/guidance/ng23 (accessed 23 Sep 2019).

3. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy

4. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

5. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment utilization and non-drug interventions for vasomotor symptoms in breast cancer survivors taking endocrine therapy: Real-world findings from the United States and Europe;Maturitas;2024-10

2. Gender-affirming hormone treatment modalities for transfemale & non-binary transfeminine individuals: A UK perspective;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

3. POESIT recommendations on management of body-identical hormones in menopausal symptoms;Climacteric;2024-07-03

4. Management of perimenopausal and menopausal symptoms;BMJ;2023-08-08

5. Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice;Maturitas;2023-08